Cargando…

Cancer Trajectories at the End of Life: is there an effect of age and gender?

BACKGROUND: Few empirical data show the pattern of functional decline at the end of life for cancer patients, especially among older patients. METHODS: In a mortality follow-back survey (the Italian Survey of the Dying of Cancer – ISDOC) a random sample of 1,271 lay caregivers were interviewed, at a...

Descripción completa

Detalles Bibliográficos
Autores principales: Costantini, Massimo, Beccaro, Monica, Higginson, Irene J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2386793/
https://www.ncbi.nlm.nih.gov/pubmed/18454854
http://dx.doi.org/10.1186/1471-2407-8-127
_version_ 1782155264149946368
author Costantini, Massimo
Beccaro, Monica
Higginson, Irene J
author_facet Costantini, Massimo
Beccaro, Monica
Higginson, Irene J
author_sort Costantini, Massimo
collection PubMed
description BACKGROUND: Few empirical data show the pattern of functional decline at the end of life for cancer patients, especially among older patients. METHODS: In a mortality follow-back survey (the Italian Survey of the Dying of Cancer – ISDOC) a random sample of 1,271 lay caregivers were interviewed, at a mean of 234 days after bereavement. The main outcome was number of days before death when the patient experienced a permanent functional decline. RESULTS: 1,249 (98%) caregivers answered the question about patient's function. The probability to be free from a functional disability was high (94%) 52 weeks before death, but was lower for older age groups (15% for those aged 85 or more) and women (8%). It remained stable until 18 weeks before death, then fell to 63% at 12 weeks and 49% at 6 weeks before death (among those aged 85 or more the figures were 50% and 41%). The pattern was consistent across sub-groups, except for patients affected by Central Nervous System tumors who experienced a longer, slower functional decline. CONCLUSION: This study provides empirical support for the declining trajectory in cancer, and suggests that the decline commences at around 12 weeks in all age groups, even among patients over 85 years.
format Text
id pubmed-2386793
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-23867932008-05-17 Cancer Trajectories at the End of Life: is there an effect of age and gender? Costantini, Massimo Beccaro, Monica Higginson, Irene J BMC Cancer Research Article BACKGROUND: Few empirical data show the pattern of functional decline at the end of life for cancer patients, especially among older patients. METHODS: In a mortality follow-back survey (the Italian Survey of the Dying of Cancer – ISDOC) a random sample of 1,271 lay caregivers were interviewed, at a mean of 234 days after bereavement. The main outcome was number of days before death when the patient experienced a permanent functional decline. RESULTS: 1,249 (98%) caregivers answered the question about patient's function. The probability to be free from a functional disability was high (94%) 52 weeks before death, but was lower for older age groups (15% for those aged 85 or more) and women (8%). It remained stable until 18 weeks before death, then fell to 63% at 12 weeks and 49% at 6 weeks before death (among those aged 85 or more the figures were 50% and 41%). The pattern was consistent across sub-groups, except for patients affected by Central Nervous System tumors who experienced a longer, slower functional decline. CONCLUSION: This study provides empirical support for the declining trajectory in cancer, and suggests that the decline commences at around 12 weeks in all age groups, even among patients over 85 years. BioMed Central 2008-05-02 /pmc/articles/PMC2386793/ /pubmed/18454854 http://dx.doi.org/10.1186/1471-2407-8-127 Text en Copyright © 2008 Costantini et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Costantini, Massimo
Beccaro, Monica
Higginson, Irene J
Cancer Trajectories at the End of Life: is there an effect of age and gender?
title Cancer Trajectories at the End of Life: is there an effect of age and gender?
title_full Cancer Trajectories at the End of Life: is there an effect of age and gender?
title_fullStr Cancer Trajectories at the End of Life: is there an effect of age and gender?
title_full_unstemmed Cancer Trajectories at the End of Life: is there an effect of age and gender?
title_short Cancer Trajectories at the End of Life: is there an effect of age and gender?
title_sort cancer trajectories at the end of life: is there an effect of age and gender?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2386793/
https://www.ncbi.nlm.nih.gov/pubmed/18454854
http://dx.doi.org/10.1186/1471-2407-8-127
work_keys_str_mv AT costantinimassimo cancertrajectoriesattheendoflifeisthereaneffectofageandgender
AT beccaromonica cancertrajectoriesattheendoflifeisthereaneffectofageandgender
AT higginsonirenej cancertrajectoriesattheendoflifeisthereaneffectofageandgender